In this podcast, 3 Cancer.Net Associate Editors discuss new research presented at the 2022 ASCO Annual Meeting in non-small cell lung cancer, non-Hodgkin lymphoma, Ewing sarcoma, and neuroblastoma. Read More >>
lymphoma
September 15, 2022 · Brielle Gregory Collins, ASCO staff
June 14, 2022 · Elizabeth H. Dibble, MD; Stephanie L. Graff, MD, FACP; Theresa A. Graves, MD, FACS; and Chelsea J. Miller, MD
In this post, several experts describe what Hodgkin lymphoma survivors who received mantle radiation should know about their increased breast cancer risk, including what to know about screening and monitoring for signs of breast cancer. Read More >>
June 3, 2022 · Greg Guthrie, ASCO staff
The ASCO Annual Meeting is being held June 3 to 7, and here is some of the notable research that will be presented today. Today’s studies explore adding nimotuzumab to chemotherapy to treat KRAS wild-type pancreatic cancer and adding ibrutinib to standard care for older adults with mantle cell lymphoma. Read More >>
February 3, 2022 · Brielle Gregory Collins, ASCO staff
In this podcast, Dr. Christopher Flowers discusses research from the 2021 American Society of Hematology (ASH) Annual Meeting and Exposition, including studies evaluating new treatments for diffuse large B-cell lymphoma and an overview of a session on improving equity in cancer clinical trials. Read More >>
June 17, 2021 · Craig A. Portell, MD
Dr. Craig A. Portell discusses what CAR T-cell therapy is, how it works, what its common side effects are, and how it’s changing the landscape of how some types of cancers are treated. Read More >>
Pages
- first page
- previous page
- page 1
- page 2
- 3 current page
- page 4
- page 5
- page 6
- next page
- last page